Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer

Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet‐based single‐cell RNA sequenc...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cancer Vol. 149; no. 12; pp. 2099 - 2115
Main Authors Lai, Huadong, Cheng, Xiaomu, Liu, Qiang, Luo, Wenqin, Liu, Mengyao, Zhang, Man, Miao, Juju, Ji, Zhongzhong, Lin, Guan Ning, Song, Weichen, Zhang, Lianhua, Bo, Juanjie, Yang, Guoliang, Wang, Jia, Gao, Wei‐Qiang
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 15.12.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet‐based single‐cell RNA sequencing (scRNA‐seq) to acquire transcriptional profiles of 36 619 single cells isolated from seven patients. Single cell transcriptional profiles matched well with the pathological basal/luminal subtypes. Notably, in T1 tumors diagnosed as luminal subtype, basal cells displayed characteristics of epithelial‐mesenchymal transition (EMT) and mainly located at the tumor‐stromal interface as well as micrometastases in the lamina propria. In one T3 tumor, muscle‐invasive tumor showed significantly higher expression of cancer stem cell markers SOX9 and SOX2 than the primary tumor. We additionally analyzed communications between tumor cells and demonstrated its relevance to basal/luminal phenotypes. Overall, our single‐cell study provides a deeper insight into the tumor cell heterogeneity associated with bladder cancer progression. What's new? Extensive heterogeneity in bladder cancer has inspired novel approaches to the investigation of underlying mechanisms, including genomic and phenotypic single‐cell analyses. In this single‐cell characterization of tumor cell heterogeneity in bladder cancer, basal‐like tumor cells were found to possess epithelial‐to‐mesenchymal transition (EMT) features, including enrichment of EMT‐associated genes. Basal‐like cells further exhibited a potential to generate luminal daughter cells, making them possible precursors for local invasion. In addition, aggressive cells with upregulation of stemness‐related genes were observed in a muscle‐invasive T3‐stage tumor. The findings suggest that invasive cell subsets within bladder cancers may serve a significant role in disease progression.
AbstractList Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet‐based single‐cell RNA sequencing (scRNA‐seq) to acquire transcriptional profiles of 36 619 single cells isolated from seven patients. Single cell transcriptional profiles matched well with the pathological basal/luminal subtypes. Notably, in T1 tumors diagnosed as luminal subtype, basal cells displayed characteristics of epithelial‐mesenchymal transition (EMT) and mainly located at the tumor‐stromal interface as well as micrometastases in the lamina propria. In one T3 tumor, muscle‐invasive tumor showed significantly higher expression of cancer stem cell markers SOX9 and SOX2 than the primary tumor. We additionally analyzed communications between tumor cells and demonstrated its relevance to basal/luminal phenotypes. Overall, our single‐cell study provides a deeper insight into the tumor cell heterogeneity associated with bladder cancer progression. What's new? Extensive heterogeneity in bladder cancer has inspired novel approaches to the investigation of underlying mechanisms, including genomic and phenotypic single‐cell analyses. In this single‐cell characterization of tumor cell heterogeneity in bladder cancer, basal‐like tumor cells were found to possess epithelial‐to‐mesenchymal transition (EMT) features, including enrichment of EMT‐associated genes. Basal‐like cells further exhibited a potential to generate luminal daughter cells, making them possible precursors for local invasion. In addition, aggressive cells with upregulation of stemness‐related genes were observed in a muscle‐invasive T3‐stage tumor. The findings suggest that invasive cell subsets within bladder cancers may serve a significant role in disease progression.
Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet-based single-cell RNA sequencing (scRNA-seq) to acquire transcriptional profiles of 36 619 single cells isolated from seven patients. Single cell transcriptional profiles matched well with the pathological basal/luminal subtypes. Notably, in T1 tumors diagnosed as luminal subtype, basal cells displayed characteristics of epithelial-mesenchymal transition (EMT) and mainly located at the tumor-stromal interface as well as micrometastases in the lamina propria. In one T3 tumor, muscle-invasive tumor showed significantly higher expression of cancer stem cell markers SOX9 and SOX2 than the primary tumor. We additionally analyzed communications between tumor cells and demonstrated its relevance to basal/luminal phenotypes. Overall, our single-cell study provides a deeper insight into the tumor cell heterogeneity associated with bladder cancer progression.Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet-based single-cell RNA sequencing (scRNA-seq) to acquire transcriptional profiles of 36 619 single cells isolated from seven patients. Single cell transcriptional profiles matched well with the pathological basal/luminal subtypes. Notably, in T1 tumors diagnosed as luminal subtype, basal cells displayed characteristics of epithelial-mesenchymal transition (EMT) and mainly located at the tumor-stromal interface as well as micrometastases in the lamina propria. In one T3 tumor, muscle-invasive tumor showed significantly higher expression of cancer stem cell markers SOX9 and SOX2 than the primary tumor. We additionally analyzed communications between tumor cells and demonstrated its relevance to basal/luminal phenotypes. Overall, our single-cell study provides a deeper insight into the tumor cell heterogeneity associated with bladder cancer progression.
Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet‐based single‐cell RNA sequencing (scRNA‐seq) to acquire transcriptional profiles of 36 619 single cells isolated from seven patients. Single cell transcriptional profiles matched well with the pathological basal/luminal subtypes. Notably, in T1 tumors diagnosed as luminal subtype, basal cells displayed characteristics of epithelial‐mesenchymal transition (EMT) and mainly located at the tumor‐stromal interface as well as micrometastases in the lamina propria. In one T3 tumor, muscle‐invasive tumor showed significantly higher expression of cancer stem cell markers SOX9 and SOX2 than the primary tumor. We additionally analyzed communications between tumor cells and demonstrated its relevance to basal/luminal phenotypes. Overall, our single‐cell study provides a deeper insight into the tumor cell heterogeneity associated with bladder cancer progression.
Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of tumor cell invasion and crosstalks within bladder tumor cells has not been determined. Here, we applied droplet‐based single‐cell RNA sequencing (scRNA‐seq) to acquire transcriptional profiles of 36 619 single cells isolated from seven patients. Single cell transcriptional profiles matched well with the pathological basal/luminal subtypes. Notably, in T1 tumors diagnosed as luminal subtype, basal cells displayed characteristics of epithelial‐mesenchymal transition (EMT) and mainly located at the tumor‐stromal interface as well as micrometastases in the lamina propria. In one T3 tumor, muscle‐invasive tumor showed significantly higher expression of cancer stem cell markers SOX9 and SOX2 than the primary tumor. We additionally analyzed communications between tumor cells and demonstrated its relevance to basal/luminal phenotypes. Overall, our single‐cell study provides a deeper insight into the tumor cell heterogeneity associated with bladder cancer progression. What's new? Extensive heterogeneity in bladder cancer has inspired novel approaches to the investigation of underlying mechanisms, including genomic and phenotypic single‐cell analyses. In this single‐cell characterization of tumor cell heterogeneity in bladder cancer, basal‐like tumor cells were found to possess epithelial‐to‐mesenchymal transition (EMT) features, including enrichment of EMT‐associated genes. Basal‐like cells further exhibited a potential to generate luminal daughter cells, making them possible precursors for local invasion. In addition, aggressive cells with upregulation of stemness‐related genes were observed in a muscle‐invasive T3‐stage tumor. The findings suggest that invasive cell subsets within bladder cancers may serve a significant role in disease progression.
Author Ji, Zhongzhong
Zhang, Lianhua
Luo, Wenqin
Zhang, Man
Song, Weichen
Lai, Huadong
Liu, Qiang
Wang, Jia
Liu, Mengyao
Lin, Guan Ning
Yang, Guoliang
Cheng, Xiaomu
Bo, Juanjie
Miao, Juju
Gao, Wei‐Qiang
Author_xml – sequence: 1
  givenname: Huadong
  surname: Lai
  fullname: Lai, Huadong
  organization: Shanghai Jiao Tong University
– sequence: 2
  givenname: Xiaomu
  surname: Cheng
  fullname: Cheng, Xiaomu
  organization: Shanghai Jiao Tong University
– sequence: 3
  givenname: Qiang
  surname: Liu
  fullname: Liu, Qiang
  organization: Shanghai Jiao Tong University
– sequence: 4
  givenname: Wenqin
  surname: Luo
  fullname: Luo, Wenqin
  organization: Shanghai Jiao Tong University
– sequence: 5
  givenname: Mengyao
  surname: Liu
  fullname: Liu, Mengyao
  organization: Shanghai Jiao Tong University
– sequence: 6
  givenname: Man
  surname: Zhang
  fullname: Zhang, Man
  organization: Shanghai Jiao Tong University
– sequence: 7
  givenname: Juju
  surname: Miao
  fullname: Miao, Juju
  organization: Shanghai Jiao Tong University
– sequence: 8
  givenname: Zhongzhong
  surname: Ji
  fullname: Ji, Zhongzhong
  organization: Shanghai Jiao Tong University
– sequence: 9
  givenname: Guan Ning
  surname: Lin
  fullname: Lin, Guan Ning
  organization: Shanghai Jiao Tong University
– sequence: 10
  givenname: Weichen
  surname: Song
  fullname: Song, Weichen
  organization: Shanghai Jiao Tong University
– sequence: 11
  givenname: Lianhua
  surname: Zhang
  fullname: Zhang, Lianhua
  organization: Shanghai Jiao Tong University
– sequence: 12
  givenname: Juanjie
  surname: Bo
  fullname: Bo, Juanjie
  organization: Shanghai Jiao Tong University
– sequence: 13
  givenname: Guoliang
  surname: Yang
  fullname: Yang, Guoliang
  email: yangguoliang@renji.com
  organization: Shanghai Jiao Tong University
– sequence: 14
  givenname: Jia
  surname: Wang
  fullname: Wang, Jia
  email: wang_jia@fudan.edu.cn
  organization: Shanghai Jiao Tong University
– sequence: 15
  givenname: Wei‐Qiang
  orcidid: 0000-0002-1989-4927
  surname: Gao
  fullname: Gao, Wei‐Qiang
  email: gao.weiqiang@sjtu.edu.cn
  organization: Shanghai Jiao Tong University
BookMark eNp1kclOwzAURS0EEqWw4A8ssYFFioeMS1QxFCGQGNaR47xQV64d7KQoOz6Bb-RLcFtWCFZPej73-l3dA7RrrAGEjimZUELYuVrICedZEe-gESVFFhFGk100Cm8kyihP99GB9wtCKE1IPELDkzKvGr4-PiVojR_vL7CHtx6MDHvsYAVCe9zNAUOrwtBKaLxB59CBs69gQHUDFqbGyqyEVyvAvq9a2_ZadMqasMbzfikMrrSoa3BYCiPBHaK9JnjD0c8co5ery-fpTXT3cD2bXtxFkqdJHFWirpq0qGuax5LEWQENy3jFCpLzimaQ0ybmkqWklhSg4Y1oGOOsTquEkJxxPkanW9_W2RDMd-VS-XUCYcD2vmRJWvCM8zwL6MkvdGF7Z8J1gcrj8C-heaDOt5R01nsHTSlVt4naOaF0SUm5rqIMVZSbKoLi7JeidWop3PAn--P-rjQM_4Pl7Ha6VXwDJg2crg
CitedBy_id crossref_primary_10_1002_ctm2_1338
crossref_primary_10_3389_fgene_2022_1027909
crossref_primary_10_1002_kjm2_12845
crossref_primary_10_1016_j_ccell_2022_11_005
crossref_primary_10_1186_s12967_025_06138_6
crossref_primary_10_1016_j_isci_2023_107722
crossref_primary_10_1016_j_arcmed_2023_102927
crossref_primary_10_1016_j_euros_2023_03_006
crossref_primary_10_1186_s13040_024_00377_x
crossref_primary_10_1007_s12032_022_01885_8
crossref_primary_10_1016_j_cca_2024_120113
crossref_primary_10_3389_fimmu_2024_1432586
crossref_primary_10_1016_j_compbiomed_2023_106795
crossref_primary_10_7717_peerj_14739
crossref_primary_10_1186_s12935_024_03465_4
crossref_primary_10_3389_fonc_2022_1020675
crossref_primary_10_1007_s00262_024_03839_7
crossref_primary_10_3389_fimmu_2023_1283792
crossref_primary_10_1016_j_eururo_2024_05_026
crossref_primary_10_1111_jcmm_70166
crossref_primary_10_3390_cancers16081532
crossref_primary_10_1038_s41598_024_52573_8
crossref_primary_10_3389_fimmu_2024_1430792
crossref_primary_10_1038_s41598_024_65594_0
crossref_primary_10_1515_oncologie_2024_0071
crossref_primary_10_2217_epi_2023_0240
crossref_primary_10_1016_j_annonc_2024_02_001
crossref_primary_10_1038_s42003_024_07343_7
crossref_primary_10_1002_advs_202300110
crossref_primary_10_1038_s41467_024_50678_2
crossref_primary_10_1016_j_heliyon_2024_e31192
crossref_primary_10_62347_VLDZ7581
crossref_primary_10_1038_s41467_024_53164_x
crossref_primary_10_1016_j_isci_2024_109928
crossref_primary_10_1038_s41598_023_49366_w
crossref_primary_10_18632_aging_205686
crossref_primary_10_1038_s41598_023_33140_z
crossref_primary_10_18632_aging_204753
crossref_primary_10_3390_ijms24076392
crossref_primary_10_3390_cancers15030809
crossref_primary_10_1002_jmv_28480
crossref_primary_10_1007_s12672_024_01548_2
crossref_primary_10_1016_j_ajt_2023_07_014
crossref_primary_10_1016_j_freeradbiomed_2024_11_001
crossref_primary_10_3390_ijms24054760
crossref_primary_10_1097_MOU_0000000000001183
crossref_primary_10_1038_s41467_024_46735_5
crossref_primary_10_1002_mc_23677
crossref_primary_10_1002_advs_202207155
crossref_primary_10_1177_11769351251323569
crossref_primary_10_32604_or_2024_045442
crossref_primary_10_3389_fimmu_2022_964393
crossref_primary_10_1016_j_fmre_2025_01_001
crossref_primary_10_1158_2159_8290_CD_24_0866
crossref_primary_10_3389_fimmu_2024_1419126
crossref_primary_10_1016_j_ydbio_2025_01_005
crossref_primary_10_1016_j_heliyon_2024_e32018
crossref_primary_10_1186_s12885_022_09810_y
crossref_primary_10_3390_metabo14060345
crossref_primary_10_1186_s12967_024_05841_0
crossref_primary_10_1186_s12979_024_00432_5
crossref_primary_10_1038_s42003_023_05668_3
crossref_primary_10_1007_s10142_022_00936_7
crossref_primary_10_1016_j_drup_2024_101116
Cites_doi 10.1016/j.cell.2019.05.031
10.1016/j.cell.2020.05.017
10.1186/s13073-020-00741-6
10.1016/j.eururo.2009.06.028
10.1038/s41588-020-00726-6
10.1038/nrc3817
10.1016/j.celrep.2018.09.042
10.1016/j.cell.2012.02.008
10.1016/j.cell.2019.10.003
10.1126/scitranslmed.3008970
10.1038/s41419-018-0877-2
10.1038/sj.onc.1210593
10.1038/s41419-021-03740-6
10.1038/s41596-020-0292-x
10.1038/nmeth.4463
10.3389/fgene.2018.00422
10.1016/j.ajpath.2019.03.012
10.1146/annurev-pathol-012513-104703
10.1038/nrm3758
10.1038/nrurol.2014.129
10.1016/j.ccell.2016.05.004
10.1038/s41585-018-0105-y
10.1101/208660
10.1186/s40425-019-0601-5
10.1093/nar/gkz204
10.1038/ncb3038
10.1002/cncr.22627
10.1016/j.tig.2018.06.001
10.1016/j.cell.2017.10.044
10.1038/s41467-020-18916-5
10.1038/nature09851
10.1007/s12307-017-0199-4
10.1016/j.eururo.2017.03.030
10.1038/s41568-020-00313-1
10.1158/1078-0432.CCR-18-0586
10.1016/j.cell.2020.03.048
10.1002/path.4886
10.1038/s41467-020-16162-3
10.1073/pnas.0506580102
10.1016/j.eururo.2017.05.040
10.1002/ijc.31369
10.1038/s41592-019-0619-0
10.1016/j.urology.2007.01.063
10.1016/j.cels.2020.08.018
10.1038/nbt.4096
10.1371/journal.pgen.1007224
10.1038/nature08460
10.20892/j.issn.2095-3941.2019.0228
10.1681/ASN.2019040335
10.1016/j.eururo.2016.06.025
10.1111/jcmm.14767
10.1038/s41467-018-06152-x
10.1016/j.eururo.2019.09.006
10.1016/j.semcancer.2019.03.004
10.1186/s13059-019-1874-1
10.1126/science.1254257
10.1158/1078-0432.CCR-18-0329
10.1002/jcb.28278
10.1016/j.cell.2018.07.036
10.1016/j.ccell.2019.02.009
10.1073/pnas.1318376111
10.1158/1078-0432.CCR-06-2330
ContentType Journal Article
Copyright 2021 UICC.
2021 UICC
Copyright_xml – notice: 2021 UICC.
– notice: 2021 UICC
DBID AAYXX
CITATION
7T5
7TO
7U9
H94
K9.
7X8
DOI 10.1002/ijc.33794
DatabaseName CrossRef
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
AIDS and Cancer Research Abstracts
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 2115
ExternalDocumentID 10_1002_ijc_33794
IJC33794
Genre article
GrantInformation_xml – fundername: Science and Technology Commission of Shanghai Municipality
  funderid: 20JC1417600
– fundername: KC Wong Foundation, Shanghai Health Bureau
  funderid: 20164Y0124
– fundername: Ministry of Science and Technology of the People's Republic of China
  funderid: 2017YFA0102900
– fundername: National Natural Science Foundation of China
  funderid: 81872406; 81630073; 81902561
– fundername: Incubating Program for clinical Research, Innovation of Renji Hospital Shanghai Jiao Tong University School of Medicine
  funderid: PYII‐17‐010
– fundername: 111 Project
  funderid: B21024
– fundername: Peak Disciplines(Type IV) of Institutions of Higher Learning in Shanghai
– fundername: Shanghai Pujiang Program
  funderid: 20PJ1409800
– fundername: The Shanghai Young Eastern Scholar Funds
  funderid: QD2018021
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
7T5
7TO
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c3654-badbf69dd184c0479ef273b29083b17e81f43c260dc1eef3faf2232d6b5008233
IEDL.DBID DR2
ISSN 0020-7136
1097-0215
IngestDate Fri Jul 11 08:00:27 EDT 2025
Fri Jul 25 06:41:24 EDT 2025
Tue Jul 01 02:28:37 EDT 2025
Thu Apr 24 22:50:40 EDT 2025
Wed Jan 22 16:27:14 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3654-badbf69dd184c0479ef273b29083b17e81f43c260dc1eef3faf2232d6b5008233
Notes Funding information
Ministry of Science and Technology of the People's Republic of China, Grant/Award Number: 2017YFA0102900; National Natural Science Foundation of China, Grant/Award Numbers: 81872406, 81630073, 81902561; 111 Project, Grant/Award Number: B21024; Science and Technology Commission of Shanghai Municipality, Grant/Award Number: 20JC1417600; KC Wong Foundation, Shanghai Health Bureau, Grant/Award Number: 20164Y0124; Shanghai Pujiang Program, Grant/Award Number: 20PJ1409800; The Shanghai Young Eastern Scholar Funds, Grant/Award Number: QD2018021; Peak Disciplines(Type IV) of Institutions of Higher Learning in Shanghai; Incubating Program for clinical Research, Innovation of Renji Hospital Shanghai Jiao Tong University School of Medicine, Grant/Award Number: PYII‐17‐010
Huadong Lai, Xiaomu Cheng contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-1989-4927
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.33794
PQID 2584273018
PQPubID 105430
PageCount 17
ParticipantIDs proquest_miscellaneous_2569373387
proquest_journals_2584273018
crossref_citationtrail_10_1002_ijc_33794
crossref_primary_10_1002_ijc_33794
wiley_primary_10_1002_ijc_33794_IJC33794
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 15 December 2021
PublicationDateYYYYMMDD 2021-12-15
PublicationDate_xml – month: 12
  year: 2021
  text: 15 December 2021
  day: 15
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: Hoboken
PublicationTitle International journal of cancer
PublicationYear 2021
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2021; 21
2019; 16
2016; 30
2020; 15
2020; 12
2020; 11
2007; 109
2019; 120
2011; 472
2009; 56
2018; 174
2017; 72
2018; 9
2017; 71
2019; 20
2020; 52
2005; 102
2019; 25
2014; 16
2014; 15
2017; 242
2018; 208660
2018; 34
2014; 6
2014; 11
2007; 69
2018; 36
2007; 26
2019; 7
2015; 15
2018; 143
2019; 30
2019; 35
2020; 181
1995; 55
2017; 171
2020; 77
2014; 111
2012; 148
2007; 13
2019; 189
2018; 25
2018; 24
2016; 11
2021; 12
2017; 14
2019; 47
2009; 462
2019; 179
2020; 24
2020; 67
2018; 11
2019; 177
2018; 14
2014; 344
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_53_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_55_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_57_1
e_1_2_10_58_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_61_1
e_1_2_10_29_1
e_1_2_10_63_1
e_1_2_10_27_1
e_1_2_10_25_1
e_1_2_10_48_1
Tachibana M (e_1_2_10_23_1) 1995; 55
e_1_2_10_24_1
e_1_2_10_45_1
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_20_1
e_1_2_10_41_1
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_54_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_56_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_59_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_31_1
e_1_2_10_50_1
e_1_2_10_60_1
e_1_2_10_62_1
e_1_2_10_64_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_26_1
e_1_2_10_47_1
References_xml – volume: 16
  start-page: 982
  year: 2014
  end-page: 991
  article-title: Bladder cancers arise from distinct urothelial sub‐populations
  publication-title: Nat Cell Biol
– volume: 77
  start-page: 420
  year: 2020
  end-page: 433
  article-title: A consensus molecular classification of muscle‐invasive bladder cancer
  publication-title: Eur Urol
– volume: 109
  start-page: 2016
  year: 2007
  end-page: 2024
  article-title: Heparin‐binding epidermal growth factor‐like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome
  publication-title: Cancer
– volume: 30
  start-page: 27
  year: 2016
  end-page: 42
  article-title: Comprehensive transcriptional analysis of early‐stage urothelial carcinoma
  publication-title: Cancer Cell
– volume: 56
  start-page: 430
  year: 2009
  end-page: 442
  article-title: Recurrence and progression of disease in non‐muscle‐invasive bladder cancer: from epidemiology to treatment strategy
  publication-title: Eur Urol
– volume: 181
  start-page: 442
  year: 2020
  article-title: Single‐cell analyses inform mechanisms of myeloid‐targeted therapies in colon cancer
  publication-title: Cell
– volume: 11
  start-page: 536
  year: 2020
  end-page: 546.e7
  article-title: The stress‐like cancer cell state is a consistent component of tumorigenesis
  publication-title: Cell Syst
– volume: 120
  start-page: 9956
  year: 2019
  end-page: 9963
  article-title: Clinical and molecular characteristics of bladder urothelial carcinoma subtypes
  publication-title: J Cell Biochem
– volume: 26
  start-page: 7859
  year: 2007
  end-page: 7871
  article-title: Molecular signatures of metaplastic carcinoma of the breast by large‐scale transcriptional profiling: identification of genes potentially related to epithelial‐mesenchymal transition
  publication-title: Oncogene
– volume: 174
  start-page: 1033
  year: 2018
  article-title: Comprehensive molecular characterization of muscle‐invasive bladder cancer
  publication-title: Cell
– volume: 15
  start-page: 1484
  year: 2020
  end-page: 1506
  article-title: CellPhoneDB: inferring cell‐cell communication from combined expression of multi‐subunit ligand‐receptor complexes
  publication-title: Nat Protoc
– volume: 7
  start-page: 132
  year: 2019
  article-title: Anti‐pancreatic tumor efficacy of a listeria‐based, Annexin A2‐targeting immunotherapy in combination with anti‐PD‐1 antibodies
  publication-title: J Immunother Cancer
– volume: 177
  start-page: 1888
  year: 2019
  end-page: 1902
  article-title: Comprehensive integration of single‐cell data
  publication-title: Cell
– volume: 6
  start-page: 244ra91
  year: 2014
  article-title: EGFR as a potential therapeutic target for a subset of muscle‐invasive bladder cancers presenting a basal‐like phenotype
  publication-title: Sci Transl Med
– volume: 11
  start-page: 400
  year: 2014
  end-page: 410
  article-title: Intrinsic basal and luminal subtypes of muscle‐invasive bladder cancer
  publication-title: Nat Rev Urol
– volume: 11
  start-page: 5077
  year: 2020
  article-title: Single‐cell RNA sequencing highlights the role of inflammatory cancer‐associated fibroblasts in bladder urothelial carcinoma
  publication-title: Nat Commun
– volume: 16
  start-page: 671
  year: 2019
  end-page: 687
  article-title: Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism
  publication-title: Cancer Biol Med
– volume: 148
  start-page: 1015
  year: 2012
  end-page: 1028
  article-title: Slug and Sox9 cooperatively determine the mammary stem cell state
  publication-title: Cell
– volume: 15
  start-page: 25
  year: 2015
  end-page: 41
  article-title: Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
  publication-title: Nat Rev Cancer
– volume: 25
  start-page: 464
  year: 2018
  article-title: Polyploid superficial cells that maintain the urothelial barrier are produced via incomplete cytokinesis and Endoreplication
  publication-title: Cell Rep
– volume: 24
  start-page: 605
  year: 2020
  end-page: 617
  article-title: An EMT‐related gene signature for the prognosis of human bladder cancer
  publication-title: J Cell Mol Med
– volume: 30
  start-page: 2159
  year: 2019
  end-page: 2176
  article-title: Single‐cell transcriptomic map of the human and mouse bladders
  publication-title: J Am Soc Nephrol
– volume: 36
  start-page: 411
  year: 2018
  end-page: 420
  article-title: Integrating single‐cell transcriptomic data across different conditions, technologies, and species
  publication-title: Nat Biotechnol
– volume: 71
  start-page: 8
  year: 2017
  end-page: 12
  article-title: Single‐cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self‐renewal of human bladder cancer stem cells
  publication-title: Eur Urol
– volume: 171
  start-page: 1611
  year: 2017
  end-page: 1624
  article-title: Single‐cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer
  publication-title: Cell
– volume: 72
  start-page: 461
  year: 2017
  end-page: 469
  article-title: Prognostic impact of a 12‐gene progression score in non‐muscle‐invasive bladder cancer: a prospective multicentre validation study
  publication-title: Eur Urol
– volume: 35
  start-page: 588
  year: 2019
  end-page: 602
  article-title: Human tumor‐associated macrophage and monocyte transcriptional landscapes reveal cancer‐specific reprogramming, biomarkers, and therapeutic targets
  publication-title: Cancer Cell
– volume: 25
  start-page: 1070
  year: 2019
  end-page: 1086
  article-title: Targeting an autocrine regulatory loop in cancer stem‐like cells impairs the progression and chemotherapy resistance of bladder cancer
  publication-title: Clin Cancer Res
– volume: 11
  start-page: 23
  year: 2018
  end-page: 39
  article-title: Positive correlation between matrix metalloproteinases and epithelial‐to‐mesenchymal transition and its association with clinical outcome in bladder cancer patients
  publication-title: Cancer Microenviron
– volume: 67
  start-page: 122
  year: 2020
  end-page: 153
  article-title: The role of SOX family members in solid tumours and metastasis
  publication-title: Semin Cancer Biol
– volume: 72
  start-page: 544
  year: 2017
  end-page: 554
  article-title: Impact of molecular subtypes in muscle‐invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
  publication-title: Eur Urol
– volume: 11
  start-page: 2540
  year: 2020
  article-title: Epithelial plasticity can generate multi‐lineage phenotypes in human and murine bladder cancers
  publication-title: Nat Commun
– volume: 102
  start-page: 15545
  year: 2005
  end-page: 15550
  article-title: Gene set enrichment analysis: a knowledge‐based approach for interpreting genome‐wide expression profiles
  publication-title: Proc Natl Acad Sci USA
– volume: 242
  start-page: 113
  year: 2017
  end-page: 125
  article-title: Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification
  publication-title: J Pathol
– volume: 208660
  year: 2018
  article-title: Continuous biomarker assessment by exhaustive survival analysis
  publication-title: bioRxiv
– volume: 55
  start-page: 3438
  year: 1995
  end-page: 3443
  article-title: Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte‐colony stimulating factor
  publication-title: Cancer Res
– volume: 14
  start-page: 1083
  year: 2017
  article-title: SCENIC: single‐cell regulatory network inference and clustering
  publication-title: Nat Methods
– volume: 12
  start-page: 446
  year: 2021
  article-title: Single‐cell analysis reveals urothelial cell heterogeneity and regenerative cues following cyclophosphamide‐induced bladder injury
  publication-title: Cell Death Dis
– volume: 16
  start-page: 23
  year: 2019
  end-page: 34
  article-title: T1 bladder cancer: current considerations for diagnosis and management
  publication-title: Nat Rev Urol
– volume: 344
  start-page: 1396
  year: 2014
  end-page: 1401
  article-title: Single‐cell RNA‐seq highlights intratumoral heterogeneity in primary glioblastoma
  publication-title: Science
– volume: 11
  start-page: 149
  year: 2016
  end-page: 174
  article-title: Origins of bladder cancer
  publication-title: Annu Rev Pathol
– volume: 143
  start-page: 2092
  year: 2018
  end-page: 2104
  article-title: Caveolin‐1, cancer and therapy resistance
  publication-title: Int J Cancer
– volume: 179
  start-page: 829
  year: 2019
  article-title: Landscape and dynamics of single immune cells in hepatocellular carcinoma
  publication-title: Cell
– volume: 20
  start-page: 296
  year: 2019
  article-title: Normalization and variance stabilization of single‐cell RNA‐seq data using regularized negative binomial regression
  publication-title: Genome Biol
– volume: 24
  start-page: 6331
  year: 2018
  end-page: 6344
  article-title: Endoglin expression on cancer‐associated fibroblasts regulates invasion and stimulates colorectal cancer metastasis
  publication-title: Clin Cancer Res
– volume: 9
  start-page: 3826
  year: 2018
  article-title: LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
  publication-title: Nat Commun
– volume: 9
  start-page: 849
  year: 2018
  article-title: TGF‐beta1‐SOX9 axis‐inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial‐to‐mesenchymal transition
  publication-title: Cell Death Dis
– volume: 69
  start-page: 780
  year: 2007
  end-page: 784
  article-title: Bladder cancer cell invasion is enhanced by cross‐talk with fibroblasts through hepatocyte growth factor
  publication-title: Urology
– volume: 9
  start-page: 422
  year: 2018
  article-title: Identification of miR‐200c and miR141‐mediated lncRNA‐mRNA crosstalks in muscle‐invasive bladder cancer subtypes
  publication-title: Front Genet
– volume: 52
  start-page: 1208
  year: 2020
  end-page: 1218
  article-title: Pan‐cancer single‐cell RNA‐seq identifies recurring programs of cellular heterogeneity
  publication-title: Nat Genet
– volume: 189
  start-page: 1637
  year: 2019
  end-page: 1653
  article-title: Silencing of LAMC2 reverses epithelial‐mesenchymal transition and inhibits angiogenesis in cholangiocarcinoma via inactivation of the epidermal growth factor receptor signaling pathway
  publication-title: Am J Pathol
– volume: 13
  start-page: 1685
  year: 2007
  end-page: 1694
  article-title: Identification and prognostic significance of an epithelial‐mesenchymal transition expression profile in human bladder tumors
  publication-title: Clin Cancer Res
– volume: 34
  start-page: 653
  year: 2018
  end-page: 665
  article-title: Single‐cell multi‐omics: an engine for new quantitative models of gene regulation
  publication-title: Trends Genet
– volume: 181
  start-page: 1612
  year: 2020
  end-page: 1625
  article-title: Intratumoral CD4(+) T cells mediate anti‐tumor cytotoxicity in human bladder cancer
  publication-title: Cell
– volume: 47
  year: 2019
  article-title: Cell lineage and communication network inference via optimization for single‐cell transcriptomics
  publication-title: Nucleic Acids Res
– volume: 21
  start-page: 104
  year: 2021
  end-page: 121
  article-title: Advances in bladder cancer biology and therapy
  publication-title: Nat Rev Cancer
– volume: 111
  start-page: 3110
  year: 2014
  end-page: 3115
  article-title: Intrinsic subtypes of high‐grade bladder cancer reflect the hallmarks of breast cancer biology
  publication-title: Proc Natl Acad Sci USA
– volume: 15
  start-page: 178
  year: 2014
  end-page: 196
  article-title: Molecular mechanisms of epithelial‐mesenchymal transition
  publication-title: Nat Rev Mol Cell Biol
– volume: 14
  year: 2018
  article-title: SOX2 regulates common and specific stem cell features in the CNS and endoderm derived organs
  publication-title: PLoS Genet
– volume: 12
  start-page: 47
  year: 2020
  article-title: Single‐cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient
  publication-title: Genome Med
– volume: 462
  start-page: 108
  year: 2009
  end-page: 122
  article-title: Systematic RNA interference reveals that oncogenic KRAS‐driven cancers require TBK1
  publication-title: Nature
– volume: 472
  start-page: 110
  year: 2011
  end-page: 145
  article-title: Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
  publication-title: Nature
– volume: 16
  start-page: 1289
  year: 2019
  end-page: 1296
  article-title: Fast, sensitive and accurate integration of single‐cell data with harmony
  publication-title: Nat Methods
– ident: e_1_2_10_25_1
  doi: 10.1016/j.cell.2019.05.031
– ident: e_1_2_10_11_1
  doi: 10.1016/j.cell.2020.05.017
– ident: e_1_2_10_12_1
  doi: 10.1186/s13073-020-00741-6
– ident: e_1_2_10_14_1
  doi: 10.1016/j.eururo.2009.06.028
– ident: e_1_2_10_54_1
  doi: 10.1038/s41588-020-00726-6
– ident: e_1_2_10_2_1
  doi: 10.1038/nrc3817
– ident: e_1_2_10_46_1
  doi: 10.1016/j.celrep.2018.09.042
– ident: e_1_2_10_57_1
  doi: 10.1016/j.cell.2012.02.008
– ident: e_1_2_10_59_1
  doi: 10.1016/j.cell.2019.10.003
– ident: e_1_2_10_64_1
  doi: 10.1126/scitranslmed.3008970
– ident: e_1_2_10_58_1
  doi: 10.1038/s41419-018-0877-2
– ident: e_1_2_10_35_1
  doi: 10.1038/sj.onc.1210593
– ident: e_1_2_10_21_1
  doi: 10.1038/s41419-021-03740-6
– ident: e_1_2_10_38_1
  doi: 10.1038/s41596-020-0292-x
– ident: e_1_2_10_37_1
  doi: 10.1038/nmeth.4463
– ident: e_1_2_10_45_1
  doi: 10.3389/fgene.2018.00422
– ident: e_1_2_10_50_1
  doi: 10.1016/j.ajpath.2019.03.012
– ident: e_1_2_10_42_1
  doi: 10.1146/annurev-pathol-012513-104703
– ident: e_1_2_10_51_1
  doi: 10.1038/nrm3758
– ident: e_1_2_10_3_1
  doi: 10.1038/nrurol.2014.129
– ident: e_1_2_10_6_1
  doi: 10.1016/j.ccell.2016.05.004
– ident: e_1_2_10_13_1
  doi: 10.1038/s41585-018-0105-y
– ident: e_1_2_10_40_1
  doi: 10.1101/208660
– volume: 55
  start-page: 3438
  year: 1995
  ident: e_1_2_10_23_1
  article-title: Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte‐colony stimulating factor
  publication-title: Cancer Res
– ident: e_1_2_10_52_1
  doi: 10.1186/s40425-019-0601-5
– ident: e_1_2_10_30_1
  doi: 10.1093/nar/gkz204
– ident: e_1_2_10_61_1
  doi: 10.1038/ncb3038
– ident: e_1_2_10_63_1
  doi: 10.1002/cncr.22627
– ident: e_1_2_10_62_1
  doi: 10.1016/j.tig.2018.06.001
– ident: e_1_2_10_34_1
  doi: 10.1016/j.cell.2017.10.044
– ident: e_1_2_10_10_1
  doi: 10.1038/s41467-020-18916-5
– ident: e_1_2_10_53_1
  doi: 10.1038/nature09851
– ident: e_1_2_10_48_1
  doi: 10.1007/s12307-017-0199-4
– ident: e_1_2_10_32_1
  doi: 10.1016/j.eururo.2017.03.030
– ident: e_1_2_10_20_1
  doi: 10.1038/s41568-020-00313-1
– ident: e_1_2_10_22_1
  doi: 10.1158/1078-0432.CCR-18-0586
– ident: e_1_2_10_60_1
  doi: 10.1016/j.cell.2020.03.048
– ident: e_1_2_10_4_1
  doi: 10.1002/path.4886
– ident: e_1_2_10_9_1
  doi: 10.1038/s41467-020-16162-3
– ident: e_1_2_10_33_1
  doi: 10.1073/pnas.0506580102
– ident: e_1_2_10_15_1
  doi: 10.1016/j.eururo.2017.05.040
– ident: e_1_2_10_47_1
  doi: 10.1002/ijc.31369
– ident: e_1_2_10_27_1
  doi: 10.1038/s41592-019-0619-0
– ident: e_1_2_10_19_1
  doi: 10.1016/j.urology.2007.01.063
– ident: e_1_2_10_43_1
  doi: 10.1016/j.cels.2020.08.018
– ident: e_1_2_10_24_1
  doi: 10.1038/nbt.4096
– ident: e_1_2_10_55_1
  doi: 10.1371/journal.pgen.1007224
– ident: e_1_2_10_31_1
  doi: 10.1038/nature08460
– ident: e_1_2_10_49_1
  doi: 10.20892/j.issn.2095-3941.2019.0228
– ident: e_1_2_10_29_1
  doi: 10.1681/ASN.2019040335
– ident: e_1_2_10_8_1
  doi: 10.1016/j.eururo.2016.06.025
– ident: e_1_2_10_16_1
  doi: 10.1111/jcmm.14767
– ident: e_1_2_10_18_1
  doi: 10.1038/s41467-018-06152-x
– ident: e_1_2_10_39_1
  doi: 10.1016/j.eururo.2019.09.006
– ident: e_1_2_10_56_1
  doi: 10.1016/j.semcancer.2019.03.004
– ident: e_1_2_10_26_1
  doi: 10.1186/s13059-019-1874-1
– ident: e_1_2_10_28_1
  doi: 10.1126/science.1254257
– ident: e_1_2_10_36_1
  doi: 10.1158/1078-0432.CCR-18-0329
– ident: e_1_2_10_44_1
  doi: 10.1002/jcb.28278
– ident: e_1_2_10_5_1
  doi: 10.1016/j.cell.2018.07.036
– ident: e_1_2_10_41_1
  doi: 10.1016/j.ccell.2019.02.009
– ident: e_1_2_10_7_1
  doi: 10.1073/pnas.1318376111
– ident: e_1_2_10_17_1
  doi: 10.1158/1078-0432.CCR-06-2330
SSID ssj0011504
Score 2.6274424
Snippet Bladder cancer represents a highly heterogeneous disease characterized by distinct histological, molecular and clinical phenotypes, and a detailed analysis of...
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 2099
SubjectTerms Basal cells
Bladder cancer
Cancer
Epithelial cells
intratumoral heterogeneity
Invasiveness
Lamina propria
Medical research
Mesenchyme
Phenotypes
single‐cell RNA sequencing
Sox9 protein
Stem cells
Transcription
Tumor cells
tumor cells communication
tumor invasion
Title Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.33794
https://www.proquest.com/docview/2584273018
https://www.proquest.com/docview/2569373387
Volume 149
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFLYQB9QLS1vEwFCZqgcuHrDjZBJxQqgjQGIOU5A4IEVexTLKjGZBglN_Qn8jv4T3nGUKaqWqt8h5URK_xd-znz8T8s2KLo-9kCyyccqk9JrpjDtmkySzMvaKB01f9JPTK3l-HV8vkaN6L0zJD9FMuKFnhHiNDq709GBBGnp3bzpRBOYE8RdrtRAQDRrqKAQ6FQPzIYNELKlZhQ7FQfPk27FoATB_h6lhnOmtkZv6C8vykofOfKY75vkdeeN__sI6Wa3wJz0uDWaDLLniI1m5qFbYP5GnHzCWDd3Lz184pU8H_WNaVVtDO0W-J7BXCqiRujFu5xiC_dIgeouFNSOwRwfAnqrC0rviUWF1PJ3O9bg5KAyaaTgZkOohhr0JNWh5k8_kqvf98uSUVcczMAPdLZlWVnvQqIUk0SBTvfOAhbTIANVp3nUp9zIykC9Zw53zkVcesIiwiY7D-l60SZaLUeG2CM1kF3BY6gFwGMhPVaZhYPVeRVIbrlPTIvu1onJTcZfjERrDvGRdFjl0ZR66skW-NqLjkrDjT0LtWtt55bPTXAAWExjw0hbZa26Dt2EnqsKN5iiTAJ6DtL4LnxRU-_eX5GfnJ-Fi-99Fd8gHgUUzXDAet8nybDJ3u4B6ZvpLMO9XT3__tg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkFouLX2JLZSaqodevGDHySZSL4iClsfugYLEpYrilwqssqtlt1I59Sf0N_aXdMZ5UCoqVb1FzkRJPDP2N_b4G4B3VvZE7KXikY1TrpTXXGfCcZskmVWxL0TQ9GCY9M_U4Xl8vgAfmrMwFT9Eu-BGnhHGa3JwWpDeumUNvbg03ShCe3oAS1TRm5jzP5605FEEdWoO5m2OoVjS8Apty6320buz0S3E_B2ohplm_wl8br6xSjC56s5numtu_qBv_N-fWIHHNQRlO5XNPIUFVz6Dh4N6k_05fPuE09nI_fz-g1b12clwh9UJ19jOiPIJTZYhcGRuQic6RmjCLIh-odyaMZqkQ2zPitKyi_JrQQny7HquJ22tMGxmoTgg0yMa-abMkPFNX8DZ_t7pbp_XFRq4iZJYcV1Y7VGpFuNEQ2T1ziMc0jJDYKdFz6XCq8hgyGSNcM5HvvAIR6RNdBy2-KKXsFiOS7cKLFM9hGKpR8xhMEQtMo1zq_dFpLQROjUdeN9oKjc1fTlV0RjlFfGyzLEr89CVHXjbik4qzo77hNYbdee1217nEuGYpDEv7cBmexsdjjqxKN14TjIJQjqM7Hv4SUG3f39JfnC4Gy5e_bvoG3jUPx0c58cHw6M1WJaUQyMkF_E6LM6mc_caQdBMbwRb_wU8tgPh
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9RAEJ8gJMQXRdR4CLoYH3zZ43a77bXhiYAXQLkQlIQHk6b7LyKX3uW4M5EnPgKf0U_izPYPYDQxvjXbadruzOz-Znf2NwBvreyL2EvFIxunXCmvuc6E4zZJMqtiX4ig6aNhsn-qDs_iswXYbs7CVPwQ7YIbeUYYr8nBJ9Zv3ZKGnn8z3ShCc3oASyrpZVS3Ye-k5Y4ipFNTMPc4RmJJQyvUk1vto_cno1uEeRenholm8Bi-NJ9Y5ZdcdOcz3TVXv7E3_uc_rMCjGoCyncpinsCCK1dh-ajeYn8KPz7hZDZyP69vaE2fnQx3WJ1uje2MCJ_QYBnCRuYmdJ5jhAbMguhXyqwZo0E6RPasKC07L78XlB7PLud60lYKw2YWSgMyPaJxb8oMmd70GZwO3n_e3ed1fQZuoiRWXBdWe1SpxSjREFW98wiGtMwQ1mnRd6nwKjIYMFkjnPORLzyCEWkTHYcNvug5LJbj0r0Alqk-ArHUI-IwGKAWmcaZ1fsiUtoInZoOvGsUlZuavJxqaIzyinZZ5tiVeejKDrxpRScVY8efhNYbbee1017mEsGYpBEv7cBmexvdjTqxKN14TjIJAjqM6_v4SUG1f39JfnC4Gy7W_l30NSwf7w3yjwfDDy_hoaQEGiG5iNdhcTaduw1EQDP9Klj6Lzi5ApA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single-cell+RNA+sequencing+reveals+the+epithelial+cell+heterogeneity+and+invasive+subpopulation+in+human+bladder+cancer&rft.jtitle=International+journal+of+cancer&rft.au=Lai%2C+Huadong&rft.au=Cheng%2C+Xiaomu&rft.au=Liu%2C+Qiang&rft.au=Luo%2C+Wenqin&rft.date=2021-12-15&rft.issn=1097-0215&rft.eissn=1097-0215&rft.volume=149&rft.issue=12&rft.spage=2099&rft_id=info:doi/10.1002%2Fijc.33794&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon